Position Summary
Our client is seeking an experienced Medical Science Liaison (MSL) to serve as a key scientific resource in the field, with a focus on supporting ongoing Phase III clinical trials. The MSL acts as a bridge between the organization and external medical experts, including Key Opinion Leaders (KOLs), investigators, and healthcare professionals. This role focuses on hematologic malignancies, particularly Acute Promyelocytic Leukemia (APML), and plays a critical role in scientific exchange, stakeholder engagement, and dissemination of clinical insights. The position involves approximately 40% travel. The contract is open‑ended for the duration of the project, requiring full engagement across the entire project timeline.
Key Responsibilities
- Serve as a scientific liaison between the organization and KOLs, investigators, and healthcare professionals (HCPs)
- Engage with KOLs and study investigators to discuss clinical data, study progress, and scientific updates
- Provide medical and scientific support for ongoing Phase III clinical trials
- Support clinical trial sites with protocol education, disease awareness, and non‑promotional scientific guidance
- Respond to complex scientific and medical inquiries related to APML and investigational therapies
- Collect and communicate field insights, clinical feedback, and unmet medical needs to internal stakeholders
- Facilitate scientific exchange initiatives and enhance study awareness within the assigned region
- Collaborate cross‑functionally with clinical, regulatory, and medical affairs teams to ensure aligned communication
- Support site identification, investigator engagement, and Investigator‑Sponsored Trials (ISTs)
- Maintain awareness of pharmacovigilance processes and support safety reporting activities as required
Qualifications & Profile
- Advanced degree (MD, PharmD, or PhD) in a relevant scientific or medical discipline
- 5–8 years of industry experience, including direct MSL or field‑based Medical Affairs roles
- Demonstrated experience supporting Phase III clinical trials
- Strong background in hematologic malignancies or rare hematology; APML experience preferred
- In‑depth understanding of clinical research, ICH‑GCP, and the regulatory environment
- Strong communication, stakeholder engagement, and analytical skills
- Ability to work independently and collaboratively in a cross‑functional environment
Additional Requirements
- Approximately 40% travel
- Contract, remote
- Educational requirements: MD/PharmD/PhD
- Experience: 5–8 years
- Job location: Germany, Poland, Romania, United States
- Job level: Senior position